Get started
Hologic, Inc.Hologic, Inc.Hologic, Inc.

Hologic, Inc.

No trades
See on Supercharts
OverviewFinancialsNewsIdeasDiscussionsTechnicalsForecastBondsETFs

1HOLX chart


Full chart

1HOLX upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪12.74 B‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
27.5
Basic EPS (TTM)
2.0 EUR
Net income (FY)
‪709.08 M‬ EUR
Revenue (FY)
‪3.62 B‬ EUR
Shares float
‪220.46 M‬
Beta (1Y)
0.01

Employees


Employees (FY)
‪7.06 K‬
Change (1Y)
+73 +1.04%
Revenue / Employee (1Y)
‪512.50 K‬ EUR
Net income / Employee (1Y)
‪100.39 K‬ EUR

About Hologic, Inc.


Sector
Health Technology
Industry
Medical Specialties
CEO
Stephen P. MacMillan
Website
hologic.com
Headquarters
Marlborough
Founded
1985
ISIN
US4364401012
FIGI
BBG01TNWV638
Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products, that focuses on women’s health and well-being through early detection and treatment. It operates through the following segments: Breast Health, Diagnostics, GYN Surgical, and Skeletal Health. The Breast Health segment is involved in a portfolio of solutions for breast cancer care primarily in the areas of radiology, breast surgery, pathology and treatment. The Diagnostics segment offers a range of products, which are used primarily to aid in the screening and diagnosis of human diseases. The GYN Surgical segment is involved in hysteroscopic endometrial ablation systems, tissue removal systems, fluid management systems, and laparoscopic tissue ablation systems and tools. The Skeletal Health segment covers the Horizon DXA and the Fluoroscan Insight FD mini C-arm. The company was founded by S. David Ellenbogen and Jay A. Stein in 1985 and is headquartered in Marlborough, MA.

Check out other big names from the same industry as 1HOLX.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

1HOLX news



Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

1HOLX highest yielding bonds


HOLX4588305
Hologic, Inc. 4.625% 01-FEB-2028
Yield to maturity
7.14%
Maturity date
Feb 1, 2028
HOLX4587167
Hologic, Inc. 4.625% 01-FEB-2028
Yield to maturity
4.83%
Maturity date
Feb 1, 2028
USU38284AF9
Hologic, Inc. 3.25% 15-FEB-2029
Yield to maturity
4.78%
Maturity date
Feb 15, 2029

See all 1HOLX bonds 

Frequently Asked Questions


The current price of 1HOLX is 57.5 EUR — it has increased by 1.77% in the past 24 hours. Watch Hologic, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on MIL exchange Hologic, Inc. stocks are traded under the ticker 1HOLX.
1HOLX stock has risen by 7.48% compared to the previous week, the month change is a −0.86% fall, over the last year Hologic, Inc. has showed a 12.75% increase.
We've gathered analysts' opinions on Hologic, Inc. future price: according to them, 1HOLX price has a max estimate of 79.67 EUR and a min estimate of 55.09 EUR. Watch 1HOLX chart and read a more detailed Hologic, Inc. stock forecast: see what analysts think of Hologic, Inc. and suggest that you do with its stocks.
1HOLX reached its all-time high on Aug 5, 2025 with the price of 59.0 EUR, and its all-time low was 46.0 EUR and was reached on May 2, 2025. View more price dynamics on 1HOLX chart.
See other stocks reaching their highest and lowest prices.
1HOLX stock is 0.00% volatile and has beta coefficient of 0.01. Track Hologic, Inc. stock price on the chart and check out the list of the most volatile stocks — is Hologic, Inc. there?
Today Hologic, Inc. has the market capitalization of ‪12.74 B‬, it has increased by 2.03% over the last week.
Yes, you can track Hologic, Inc. financials in yearly and quarterly reports right on TradingView.
Hologic, Inc. is going to release the next earnings report on Nov 3, 2025. Keep track of upcoming events with our Earnings Calendar.
1HOLX earnings for the last quarter are 0.92 EUR per share, whereas the estimation was 0.90 EUR resulting in a 1.52% surprise. The estimated earnings for the next quarter are 0.93 EUR per share. See more details about Hologic, Inc. earnings.
Hologic, Inc. revenue for the last quarter amounts to ‪869.11 M‬ EUR, despite the estimated figure of ‪857.75 M‬ EUR. In the next quarter, revenue is expected to reach ‪875.36 M‬ EUR.
1HOLX net income for the last quarter is ‪165.45 M‬ EUR, while the quarter before that showed ‪−16.08 M‬ EUR of net income which accounts for ‪1.13 K‬% change. Track more Hologic, Inc. financial stats to get the full picture.
No, 1HOLX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Sep 24, 2025, the company has ‪7.06 K‬ employees. See our rating of the largest employees — is Hologic, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Hologic, Inc. EBITDA is ‪1.06 B‬ EUR, and current EBITDA margin is 31.74%. See more stats in Hologic, Inc. financial statements.
Like other stocks, 1HOLX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Hologic, Inc. stock right from TradingView charts — choose your broker and connect to your account.